Biguanide is an orally active antihyperglycemic agent. Biguanide inhibits mitochondrial ATP production, activates the LKB1-AMPK signaling pathway, and damages the energy homeostasis. Biguanide enhances insulin-receptor activation and downstream signaling. Biguanide exhibits potential in ameliorating the type 2 diabetes and the insulin-associated cancers[1].
Molekulargewicht:
101.11
Reinheit:
98.07
CAS Nummer:
[56-03-1]
Formel:
C2H7N5
Target-Kategorie:
AMPK,Insulin Receptor,Mitochondrial Metabolism
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten